News

The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...
Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...
Spokane's Gestalt Diagnostics lands $7.5M in funding to enhance its AI tools for digital pathology, aiming to improve cancer ...
The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...
Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.
An urgent recall has been issued for a bread brand sold throughout six U.S. states that could contain “glass fragments,” ...
In a research report published in Psychedelics, Emory University investigators have uncovered the complex motivations driving ...
President Trump's blanket return-to-office mandate has caused chaos and frustration among federal employees and a potential ...
At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for ...
A federal appeals court has paused a judge’s order to bring a Turkish Tufts University student from a Louisiana immigration ...
Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...
(UroToday.com) Today at the Engineering and Urology Society (EUS) Poster Session, Dr. Dan Stoianovici presented early clinical experience with ProBot, a newly developed robotic system designed to ...